EPS

FedEx Reports Higher Third Quarter Diluted EPS of $3.51 and Adjusted Diluted EPS of $3.86

Retrieved on: 
Thursday, March 21, 2024
Logistics, Supply Chain Management, Air, Retail, Transport, Delivery Services, Failure, FedEx, Automation, Railway Labor Act, Annual report, Growth, MTM, Disease, EPS, DRIVE, Business, Name, ASR, EDT, Sale, Capital, Table, Security (finance), Insurance, Bank statement, United, FedEx Express, FedEx Ground, Investment, Atmosphere, Safety, GAAP, Geography, FDX, ETR, Share repurchase

FedEx Ground operating results increased due to lower structural costs resulting from DRIVE initiatives, higher base yield, and reduced self-insurance costs.

Key Points: 
  • FedEx Ground operating results increased due to lower structural costs resulting from DRIVE initiatives, higher base yield, and reduced self-insurance costs.
  • Cost per package was flat, as lower line-haul expense and improved dock productivity offset higher first- and last-mile costs.
  • The year-to-date decrease in outstanding shares benefited third quarter results by $0.09 per diluted share.
  • FedEx expects to repurchase an additional $500 million of common stock during the fiscal fourth quarter, which will bring the fiscal 2024 buyback total to $2.5 billion.

Accenture Reports Second-Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, March 21, 2024
Technology, Finance, Security, Consulting, Professional Services, Software, Networks, Data Analytics, Data Management, Artificial Intelligence, Managed services, Public, EPS, Webcast, ESG, Financial services, EDT, GAAP, Multimedia, Share repurchase, Service, Movement, Video game

Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2024 ended February 29, 2024.

Key Points: 
  • Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2024 ended February 29, 2024.
  • The adjusted effective tax rate for the second quarter of fiscal 2024 was 18.8%, compared with 20.4% for the second quarter of fiscal 2023.
  • Accenture’s business outlook for fiscal 2024 continues to assume that the foreign-exchange impact on its results in U.S. dollars will be flat compared with fiscal 2023.
  • Accenture will host a conference call at 8:00 a.m. EDT today to discuss its second quarter of fiscal 2024 financial results.

Shoe Carnival Reports Fourth Quarter and Fiscal 2023 Results

Retrieved on: 
Thursday, March 21, 2024
Retail, Department Stores, Other Retail, Fashion, Comparable, CRM, Growth, EPS, Webcast, Acquisition, Public expenditure, Table, Shoe Carnival, Shareholder, Adjustment, Investment, GAAP, Family, Share repurchase, Fiscal, Annual general meeting, Weather

Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, today reported results for the fourth quarter and fiscal year ended February 3, 2024 (“Fiscal 2023”) and provided annual guidance for its fiscal year ending on February 1, 2025 (“Fiscal 2024”).

Key Points: 
  • Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, today reported results for the fourth quarter and fiscal year ended February 3, 2024 (“Fiscal 2023”) and provided annual guidance for its fiscal year ending on February 1, 2025 (“Fiscal 2024”).
  • Net sales achieved at the high end of the Company’s expectation, totaling $280.2 million in fourth quarter 2023 and $1.176 billion in Fiscal 2023.
  • The Company’s financial results for fourth quarter 2023 were consistent with the preliminary results previously announced.
  • Net sales in fourth quarter 2023 were $280.2 million, down 3.6 percent compared to fourth quarter 2022.

Bureau Veritas Targets a Step Change in Growth and Shareholder Returns

Retrieved on: 
Wednesday, March 20, 2024
Supply Chain Management, Consumer Electronics, Retail, Technology, Manufacturing, Other Technology, Other Manufacturing, Connectivity, Innovation, Growth, Environment, Urbanization, EPS, Digitalization, Knowledge, Climate, Bureau Veritas, DNA, History, Ethics, Biodiversity, Capital market, CSR, LEAP, Machine learning, Workplace, Artificial intelligence

Our new strategy, LEAP I 28, is a new chapter in our history as we aim to achieve a step change in our leadership and performance, both in terms of growth and shareholder returns.

Key Points: 
  • Our new strategy, LEAP I 28, is a new chapter in our history as we aim to achieve a step change in our leadership and performance, both in terms of growth and shareholder returns.
  • We are targeting mid-to-high single digit organic revenue growth, consistent adjusted operating margin improvement and double-digit shareholder returns based on EPS CAGR and dividend yield.
  • Bureau Veritas will actively manage its Portfolio to attain market leadership positions on prioritized and focused businesses.
  • As a service company, Bureau Veritas’ people skills and knowledge are critical to its market differentiation and business success.

Citi Trends Announces Fourth Quarter and Fiscal 2023 Results

Retrieved on: 
Tuesday, March 19, 2024
Footwear, Fashion, Retail, Jewelry, Other Retail, Home Goods, Department Stores, Growth, Face, EPS, Citi Trends, African Americans, CTRN, GAAP, Share repurchase, Marketing, Total, Video game

Our strong execution of the business across our strategic priorities fueled our performance throughout the quarter.

Key Points: 
  • Our strong execution of the business across our strategic priorities fueled our performance throughout the quarter.
  • Midway through the first quarter, we are encouraged by our positive comp results and sequential improvement versus prior quarters driven by traffic growth and strong conversion.
  • At the end of fiscal 2023, $50.0 million remained available under the Company’s share repurchase program.
  • The live broadcast of Citi Trends' conference call will be available online at the Company's website, cititrends.com, under the Investor Relations section, beginning today at 9:00 a.m.

Guess?, Inc. Reports Fiscal Year 2024 Fourth Quarter Results

Retrieved on: 
Wednesday, March 20, 2024
Online Retail, Fashion, Retail, Footwear, Delivery Services, Generation, GES, Entrepreneurship, EPS, CUSIP, Generation Z, Sale, Acquisition, Table, Clothes horse, Note, GAAP, Government, Video game

For the fourth quarter of the fiscal year ended February 3, 2024 (“fiscal 2024”), the Company recorded GAAP net earnings of $115.3 million, a 20% increase from $95.8 million for the same prior-year quarter.

Key Points: 
  • For the fourth quarter of the fiscal year ended February 3, 2024 (“fiscal 2024”), the Company recorded GAAP net earnings of $115.3 million, a 20% increase from $95.8 million for the same prior-year quarter.
  • The Company’s fourth quarter fiscal 2024 results included 14 weeks, while the fourth quarter of the fiscal year ended January 28, 2023 (“fiscal 2023”) results included 13 weeks.
  • For the fourth quarter of fiscal 2024, the Company’s adjusted net earnings were $110.8 million, a 13% increase from $98.2 million for the same prior-year quarter.
  • Total net revenue for the fourth quarter of fiscal 2024 increased 9% to $891.1 million from $817.8 million in the same prior-year quarter.

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio

Retrieved on: 
Monday, March 18, 2024
Mental Health, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, BMY, Psychosis, Bristol Myers Squibb, Citigroup, Growth, Schizophrenia, Goldman Sachs, KarXT, EPS, Patient, Simpson Thacher & Bartlett, Acquisition, BMS, LLP, Therapy, GAAP, Covington & Burling, Bipolar I disorder, PDUFA, Pharmaceutical industry

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
  • With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb (“BMS”).
  • “We are excited to expand our neuroscience portfolio as we welcome Karuna to Bristol Myers Squibb,” said Chris Boerner, Ph.D., Chief Executive Officer, Bristol Myers Squibb.
  • Bristol Myers Squibb expects to offset the operational expenses of the transaction through continued disciplined resource allocation, cost efficiencies and portfolio prioritization.

RevBits Sweeps the 2024 Globee Cybersecurity Awards Across Multiple Solutions and Categories

Retrieved on: 
Monday, March 18, 2024
Apps, Applications, Mobile, Wireless, Technology, Security, Telecommunications, Professional Services, Software, Networks, Data Analytics, Artificial Intelligence, EPS, CIP, DT, CISO, Artificial intelligence, LogRhythm, EDR, Machine learning, PAM, Arms industry

It confirms both the breadth and depth of our solution is unrivaled in the crowded cybersecurity market,” said David Schiffer, CEO.

Key Points: 
  • It confirms both the breadth and depth of our solution is unrivaled in the crowded cybersecurity market,” said David Schiffer, CEO.
  • “One of our tag lines is ‘Every CISO’s Dream’ and RevBits’ Cybersecurity Intelligent Platform, truly is that.”
    “Innovation is at the core of everything we do,” said Mucteba Celik, CTO.
  • And still every single one of our products has innovative and unique features that make it stand out from other mainstream solutions.
  • RevBits is taking cybersecurity to the next level, innovating new capabilities with multiple patented technologies to ensure our competitive advantage.

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

Retrieved on: 
Monday, March 18, 2024
Mental Health, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, BMY, Psychosis, Bristol Myers Squibb, Citigroup, Growth, Schizophrenia, KarXT, Goldman Sachs, EPS, Patient, Neuroscience, Simpson Thacher & Bartlett, Acquisition, BMS, LLP, PRTC, Therapy, GAAP, Covington & Burling, Psychiatry, Bipolar I disorder, PDUFA, Pharmaceutical industry

The full text of the announcement from Bristol Myers Squibb is as follows:

Key Points: 
  • The full text of the announcement from Bristol Myers Squibb is as follows:
    Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience
    PRINCETON, N.J.-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
  • With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb (“BMS”).
  • “We are excited to expand our neuroscience portfolio as we welcome Karuna to Bristol Myers Squibb,” said Chris Boerner, Ph.D., Chief Executive Officer, Bristol Myers Squibb.
  • Gordon Dyal & Co. and Citi are serving as financial advisors to Bristol Myers Squibb, and Covington & Burling LLP is serving as legal counsel.

Carlisle Companies to Acquire MTL Holdings, a Leader in Edge Metal and Non-Insulated Architectural Wall Systems

Retrieved on: 
Monday, March 18, 2024
Construction & Property, Environment, Other Manufacturing, Building Systems, Machine Tools, Metalworking & Metallurgy, Green Technology, Other Construction & Property, Manufacturing, Citadel, CSL, Chair, MTL, EPS, Acquisition, Vision 2030, ACM, Latham & Watkins, MTL (transport company), Dorsey & Whitney

MTL is a leading provider of pre-fabricated edge metal for commercial roofing systems.

Key Points: 
  • MTL is a leading provider of pre-fabricated edge metal for commercial roofing systems.
  • Under the terms of the agreement, Carlisle will purchase MTL for $410 million in cash.
  • MTL is widely recognized as a best-in-class provider of high-performance, pre-fabricated perimeter edge metal systems and non-insulated architectural metal wall systems for commercial, institutional, and industrial buildings.
  • MTL establishes Carlisle as one of the industry’s most comprehensive providers of architectural metal products, including “roof-to-grass” color coordinated metal building envelope solutions.